HEADER HYDROLASE/HYDROLASE INHIBITOR 27-JAN-16 5HTZ TITLE BACE1 IN COMPLEX WITH (S)-5-(3-CHLORO-5-(5-(PROP-1-YN-1-YL)PYRIDIN-3- TITLE 2 YL)THIOPHEN-2-YL)-2,5-DIMETHYL-1,2,4-THIADIAZINAN-3-IMINIUM 1,1- TITLE 3 DIOXIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 43-454; COMPND 5 SYNONYM: ASPARTYL PROTEASE 2,ASP 2,BETA-SITE AMYLOID PRECURSOR COMPND 6 PROTEIN CLEAVING ENZYME 1,BETA-SITE APP CLEAVING ENZYME 1,MEMAPSIN-2, COMPND 7 MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 8 EC: 3.4.23.46; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE1, BACE, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALZHEIMER'S, ASPARTYL PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.ORTH REVDAT 3 04-JAN-17 5HTZ 1 JRNL REVDAT 2 30-NOV-16 5HTZ 1 JRNL REVDAT 1 09-NOV-16 5HTZ 0 JRNL AUTH J.D.SCOTT,S.W.LI,A.P.BRUNSKILL,X.CHEN,K.COX,J.N.CUMMING, JRNL AUTH 2 M.FORMAN,E.J.GILBERT,R.A.HODGSON,L.A.HYDE,Q.JIANG,U.ISERLOH, JRNL AUTH 3 I.KAZAKEVICH,R.KUVELKAR,H.MEI,J.MEREDITH,J.MISIASZEK,P.ORTH, JRNL AUTH 4 L.M.ROSSITER,M.SLATER,J.STONE,C.O.STRICKLAND,J.H.VOIGT, JRNL AUTH 5 G.WANG,H.WANG,Y.WU,W.J.GREENLEE,E.M.PARKER,M.E.KENNEDY, JRNL AUTH 6 A.W.STAMFORD JRNL TITL DISCOVERY OF THE 3-IMINO-1,2,4-THIADIAZINANE 1,1-DIOXIDE JRNL TITL 2 DERIVATIVE VERUBECESTAT (MK-8931)-A BETA-SITE AMYLOID JRNL TITL 3 PRECURSOR PROTEIN CLEAVING ENZYME 1 INHIBITOR FOR THE JRNL TITL 4 TREATMENT OF ALZHEIMER'S DISEASE. JRNL REF J. MED. CHEM. V. 59 10435 2016 JRNL REFN ISSN 1520-4804 JRNL PMID 27933948 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00307 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 73951 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.060 REMARK 3 FREE R VALUE TEST SET COUNT : 3004 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.78 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 5282 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2199 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5073 REMARK 3 BIN R VALUE (WORKING SET) : 0.2183 REMARK 3 BIN FREE R VALUE : 0.2579 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.96 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 209 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6092 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 802 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.77510 REMARK 3 B22 (A**2) : -5.26020 REMARK 3 B33 (A**2) : 3.48510 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.234 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6312 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8591 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2095 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 145 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 933 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6312 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 799 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7806 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.13 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.79 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HTZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000217750. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74098 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.2 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 27.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.71100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 3350, 200MM NA/K TARTRATE, REMARK 280 100MM HEPES PH7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.17650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.81800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.98900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.81800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.17650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.98900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 43 REMARK 465 PRO A 44 REMARK 465 ARG A 45 REMARK 465 GLU A 46 REMARK 465 THR A 47 REMARK 465 ASP A 48 REMARK 465 GLU A 49 REMARK 465 GLU A 50 REMARK 465 PRO A 51 REMARK 465 GLU A 52 REMARK 465 GLU A 53 REMARK 465 PRO A 54 REMARK 465 GLY A 55 REMARK 465 ARG A 56 REMARK 465 VAL A 373 REMARK 465 ALA A 374 REMARK 465 THR A 375 REMARK 465 PRO A 448 REMARK 465 GLN A 449 REMARK 465 THR A 450 REMARK 465 ASP A 451 REMARK 465 GLU A 452 REMARK 465 SER A 453 REMARK 465 THR A 454 REMARK 465 LEU B 43 REMARK 465 PRO B 44 REMARK 465 ARG B 45 REMARK 465 GLU B 46 REMARK 465 THR B 47 REMARK 465 ASP B 48 REMARK 465 GLU B 49 REMARK 465 GLU B 50 REMARK 465 PRO B 51 REMARK 465 GLU B 52 REMARK 465 GLU B 53 REMARK 465 PRO B 54 REMARK 465 GLY B 55 REMARK 465 ARG B 56 REMARK 465 THR B 375 REMARK 465 ILE B 447 REMARK 465 PRO B 448 REMARK 465 GLN B 449 REMARK 465 THR B 450 REMARK 465 ASP B 451 REMARK 465 GLU B 452 REMARK 465 SER B 453 REMARK 465 THR B 454 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 224 CG CD OE1 NE2 REMARK 470 GLU A 441 CB CG CD OE1 OE2 REMARK 470 GLN B 224 CG CD OE1 NE2 REMARK 470 VAL B 373 CB CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 150 55.85 -104.14 REMARK 500 TRP A 258 -81.65 -142.20 REMARK 500 ALA A 384 35.24 -99.89 REMARK 500 HIS B 150 51.85 -104.97 REMARK 500 TRP B 258 -82.02 -142.14 REMARK 500 ALA B 384 35.61 -99.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1003 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH B 998 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH B 999 DISTANCE = 5.93 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 66J A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 66J B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5HU0 RELATED DB: PDB REMARK 900 RELATED ID: 5HU1 RELATED DB: PDB DBREF 5HTZ A 43 454 UNP P56817 BACE1_HUMAN 43 454 DBREF 5HTZ B 43 454 UNP P56817 BACE1_HUMAN 43 454 SEQRES 1 A 412 LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU PRO GLY SEQRES 2 A 412 ARG ARG GLY SER PHE VAL GLU MET VAL ASP ASN LEU ARG SEQRES 3 A 412 GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET THR VAL SEQRES 4 A 412 GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL ASP THR SEQRES 5 A 412 GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO HIS PRO SEQRES 6 A 412 PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SER THR SEQRES 7 A 412 TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO TYR THR SEQRES 8 A 412 GLN GLY LYS TRP GLU GLY GLU LEU GLY THR ASP LEU VAL SEQRES 9 A 412 SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG ALA ASN SEQRES 10 A 412 ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE ILE ASN SEQRES 11 A 412 GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA TYR ALA SEQRES 12 A 412 GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO PHE PHE SEQRES 13 A 412 ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN LEU PHE SEQRES 14 A 412 SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU ASN GLN SEQRES 15 A 412 SER GLU VAL LEU ALA SER VAL GLY GLY SER MET ILE ILE SEQRES 16 A 412 GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER LEU TRP SEQRES 17 A 412 TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU VAL ILE SEQRES 18 A 412 ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU LYS MET SEQRES 19 A 412 ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE VAL ASP SEQRES 20 A 412 SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS VAL PHE SEQRES 21 A 412 GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SER THR SEQRES 22 A 412 GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU GLN LEU SEQRES 23 A 412 VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN ILE PHE SEQRES 24 A 412 PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL THR ASN SEQRES 25 A 412 GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN TYR LEU SEQRES 26 A 412 ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP ASP CYS SEQRES 27 A 412 TYR LYS PHE ALA ILE SER GLN SER SER THR GLY THR VAL SEQRES 28 A 412 MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL VAL PHE SEQRES 29 A 412 ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SER ALA SEQRES 30 A 412 CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA VAL GLU SEQRES 31 A 412 GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS GLY TYR SEQRES 32 A 412 ASN ILE PRO GLN THR ASP GLU SER THR SEQRES 1 B 412 LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU PRO GLY SEQRES 2 B 412 ARG ARG GLY SER PHE VAL GLU MET VAL ASP ASN LEU ARG SEQRES 3 B 412 GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET THR VAL SEQRES 4 B 412 GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL ASP THR SEQRES 5 B 412 GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO HIS PRO SEQRES 6 B 412 PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SER THR SEQRES 7 B 412 TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO TYR THR SEQRES 8 B 412 GLN GLY LYS TRP GLU GLY GLU LEU GLY THR ASP LEU VAL SEQRES 9 B 412 SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG ALA ASN SEQRES 10 B 412 ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE ILE ASN SEQRES 11 B 412 GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA TYR ALA SEQRES 12 B 412 GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO PHE PHE SEQRES 13 B 412 ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN LEU PHE SEQRES 14 B 412 SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU ASN GLN SEQRES 15 B 412 SER GLU VAL LEU ALA SER VAL GLY GLY SER MET ILE ILE SEQRES 16 B 412 GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER LEU TRP SEQRES 17 B 412 TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU VAL ILE SEQRES 18 B 412 ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU LYS MET SEQRES 19 B 412 ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE VAL ASP SEQRES 20 B 412 SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS VAL PHE SEQRES 21 B 412 GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SER THR SEQRES 22 B 412 GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU GLN LEU SEQRES 23 B 412 VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN ILE PHE SEQRES 24 B 412 PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL THR ASN SEQRES 25 B 412 GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN TYR LEU SEQRES 26 B 412 ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP ASP CYS SEQRES 27 B 412 TYR LYS PHE ALA ILE SER GLN SER SER THR GLY THR VAL SEQRES 28 B 412 MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL VAL PHE SEQRES 29 B 412 ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SER ALA SEQRES 30 B 412 CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA VAL GLU SEQRES 31 B 412 GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS GLY TYR SEQRES 32 B 412 ASN ILE PRO GLN THR ASP GLU SER THR HET 66J A 501 26 HET 66J B 501 26 HETNAM 66J (3E,5S)-5-{3-CHLORO-5-[5-(PROP-1-YN-1-YL)PYRIDIN-3- HETNAM 2 66J YL]THIOPHEN-2-YL}-2,5-DIMETHYL-1,2,4-THIADIAZINAN-3- HETNAM 3 66J IMINE 1,1-DIOXIDE FORMUL 3 66J 2(C17 H17 CL N4 O2 S2) FORMUL 5 HOH *802(H2 O) HELIX 1 AA1 GLN A 114 SER A 118 5 5 HELIX 2 AA2 TYR A 184 ALA A 188 5 5 HELIX 3 AA3 PRO A 196 THR A 205 1 10 HELIX 4 AA4 ASN A 223 SER A 230 1 8 HELIX 5 AA5 ASP A 241 SER A 243 5 3 HELIX 6 AA6 ASP A 277 TYR A 283 5 7 HELIX 7 AA7 LYS A 299 SER A 313 1 15 HELIX 8 AA8 PRO A 319 LEU A 324 1 6 HELIX 9 AA9 PRO A 337 PHE A 341 5 5 HELIX 10 AB1 LEU A 362 TYR A 366 1 5 HELIX 11 AB2 GLY A 395 GLU A 400 1 6 HELIX 12 AB3 ASP A 439 GLY A 444 5 6 HELIX 13 AB4 GLN B 114 SER B 118 5 5 HELIX 14 AB5 TYR B 184 ALA B 188 5 5 HELIX 15 AB6 PRO B 196 THR B 205 1 10 HELIX 16 AB7 ASN B 223 SER B 230 1 8 HELIX 17 AB8 ASP B 241 SER B 243 5 3 HELIX 18 AB9 ASP B 277 TYR B 283 5 7 HELIX 19 AC1 LYS B 299 SER B 313 1 15 HELIX 20 AC2 PRO B 319 LEU B 324 1 6 HELIX 21 AC3 PRO B 337 PHE B 341 5 5 HELIX 22 AC4 LEU B 362 TYR B 366 1 5 HELIX 23 AC5 GLY B 395 GLU B 400 1 6 HELIX 24 AC6 ASP B 439 GLY B 444 5 6 SHEET 1 AA1 8 LEU A 67 LYS A 70 0 SHEET 2 AA1 8 GLY A 74 VAL A 81 -1 O TYR A 76 N ARG A 68 SHEET 3 AA1 8 GLN A 86 ASP A 93 -1 O ILE A 90 N VAL A 77 SHEET 4 AA1 8 GLY A 178 GLY A 181 1 O LEU A 180 N LEU A 91 SHEET 5 AA1 8 PHE A 99 GLY A 102 -1 N ALA A 100 O ILE A 179 SHEET 6 AA1 8 VAL A 156 ASP A 167 1 O ILE A 163 N VAL A 101 SHEET 7 AA1 8 GLY A 135 SER A 147 -1 N GLU A 138 O GLU A 165 SHEET 8 AA1 8 ARG A 122 TYR A 132 -1 N LYS A 126 O LEU A 141 SHEET 1 AA2 4 LEU A 67 LYS A 70 0 SHEET 2 AA2 4 GLY A 74 VAL A 81 -1 O TYR A 76 N ARG A 68 SHEET 3 AA2 4 GLY A 135 SER A 147 -1 O SER A 147 N THR A 80 SHEET 4 AA2 4 ARG A 122 TYR A 132 -1 N LYS A 126 O LEU A 141 SHEET 1 AA3 5 GLY A 233 ILE A 237 0 SHEET 2 AA3 5 PHE A 211 LEU A 215 -1 N GLN A 214 O SER A 234 SHEET 3 AA3 5 PHE A 402 ASP A 407 -1 O VAL A 404 N LEU A 213 SHEET 4 AA3 5 ARG A 412 SER A 418 -1 O ALA A 416 N TYR A 403 SHEET 5 AA3 5 TYR A 245 PRO A 253 -1 N THR A 252 O ILE A 413 SHEET 1 AA4 5 GLU A 261 VAL A 262 0 SHEET 2 AA4 5 SER A 286 VAL A 288 -1 O SER A 286 N VAL A 262 SHEET 3 AA4 5 THR A 392 MET A 394 1 O MET A 394 N ILE A 287 SHEET 4 AA4 5 LEU A 295 PRO A 298 -1 N ARG A 296 O VAL A 393 SHEET 5 AA4 5 ILE A 385 SER A 388 1 O SER A 386 N LEU A 297 SHEET 1 AA5 5 GLN A 272 ASP A 273 0 SHEET 2 AA5 5 ILE A 264 ILE A 269 -1 N ILE A 269 O GLN A 272 SHEET 3 AA5 5 ILE A 344 MET A 349 -1 O TYR A 347 N ARG A 266 SHEET 4 AA5 5 GLN A 355 ILE A 361 -1 O ILE A 361 N ILE A 344 SHEET 5 AA5 5 ALA A 430 VAL A 436 -1 O GLU A 432 N ARG A 358 SHEET 1 AA6 3 VAL A 329 TRP A 331 0 SHEET 2 AA6 3 ASP A 379 PHE A 383 -1 O ASP A 379 N TRP A 331 SHEET 3 AA6 3 LEU A 367 VAL A 370 -1 N ARG A 368 O LYS A 382 SHEET 1 AA7 8 LEU B 67 LYS B 70 0 SHEET 2 AA7 8 GLY B 74 VAL B 81 -1 O TYR B 76 N ARG B 68 SHEET 3 AA7 8 GLN B 86 ASP B 93 -1 O VAL B 92 N TYR B 75 SHEET 4 AA7 8 GLY B 178 GLY B 181 1 O LEU B 180 N LEU B 91 SHEET 5 AA7 8 PHE B 99 GLY B 102 -1 N ALA B 100 O ILE B 179 SHEET 6 AA7 8 VAL B 156 ASP B 167 1 O ILE B 163 N VAL B 101 SHEET 7 AA7 8 GLY B 135 SER B 147 -1 N GLU B 138 O GLU B 165 SHEET 8 AA7 8 ARG B 122 TYR B 132 -1 N VAL B 130 O TRP B 137 SHEET 1 AA8 4 LEU B 67 LYS B 70 0 SHEET 2 AA8 4 GLY B 74 VAL B 81 -1 O TYR B 76 N ARG B 68 SHEET 3 AA8 4 GLY B 135 SER B 147 -1 O SER B 147 N THR B 80 SHEET 4 AA8 4 ARG B 122 TYR B 132 -1 N VAL B 130 O TRP B 137 SHEET 1 AA9 5 GLY B 233 ILE B 237 0 SHEET 2 AA9 5 PHE B 211 LEU B 215 -1 N GLN B 214 O SER B 234 SHEET 3 AA9 5 PHE B 402 ASP B 407 -1 O VAL B 404 N LEU B 213 SHEET 4 AA9 5 ARG B 412 SER B 418 -1 O ALA B 416 N TYR B 403 SHEET 5 AA9 5 TYR B 245 PRO B 253 -1 N THR B 252 O ILE B 413 SHEET 1 AB1 5 GLU B 261 VAL B 262 0 SHEET 2 AB1 5 SER B 286 VAL B 288 -1 O SER B 286 N VAL B 262 SHEET 3 AB1 5 THR B 392 MET B 394 1 O MET B 394 N ILE B 287 SHEET 4 AB1 5 LEU B 295 PRO B 298 -1 N ARG B 296 O VAL B 393 SHEET 5 AB1 5 ILE B 385 SER B 388 1 O SER B 386 N LEU B 297 SHEET 1 AB2 5 GLN B 272 ASP B 273 0 SHEET 2 AB2 5 ILE B 264 ILE B 269 -1 N ILE B 269 O GLN B 272 SHEET 3 AB2 5 ILE B 344 MET B 349 -1 O TYR B 347 N ARG B 266 SHEET 4 AB2 5 GLN B 355 ILE B 361 -1 O ILE B 361 N ILE B 344 SHEET 5 AB2 5 ALA B 430 VAL B 436 -1 O GLU B 432 N ARG B 358 SHEET 1 AB3 3 VAL B 329 TRP B 331 0 SHEET 2 AB3 3 ASP B 379 PHE B 383 -1 O ASP B 379 N TRP B 331 SHEET 3 AB3 3 LEU B 367 VAL B 370 -1 N ARG B 368 O LYS B 382 SSBOND 1 CYS A 216 CYS A 420 1555 1555 2.05 SSBOND 2 CYS A 278 CYS A 443 1555 1555 2.03 SSBOND 3 CYS A 330 CYS A 380 1555 1555 2.04 SSBOND 4 CYS B 216 CYS B 420 1555 1555 2.06 SSBOND 5 CYS B 278 CYS B 443 1555 1555 2.04 SSBOND 6 CYS B 330 CYS B 380 1555 1555 2.04 CISPEP 1 SER A 83 PRO A 84 0 -1.89 CISPEP 2 ARG A 189 PRO A 190 0 4.40 CISPEP 3 TYR A 283 ASP A 284 0 3.60 CISPEP 4 GLY A 433 PRO A 434 0 -3.99 CISPEP 5 SER B 83 PRO B 84 0 -2.62 CISPEP 6 ARG B 189 PRO B 190 0 5.89 CISPEP 7 TYR B 283 ASP B 284 0 3.66 CISPEP 8 GLY B 433 PRO B 434 0 -3.28 SITE 1 AC1 14 SER A 71 GLN A 73 GLY A 74 ASP A 93 SITE 2 AC1 14 GLY A 95 TYR A 132 GLN A 134 TRP A 176 SITE 3 AC1 14 ASP A 289 SER A 290 GLY A 291 THR A 292 SITE 4 AC1 14 ALA A 396 HOH A 713 SITE 1 AC2 13 SER B 71 GLN B 73 GLY B 74 LEU B 91 SITE 2 AC2 13 ASP B 93 TYR B 132 GLN B 134 TRP B 176 SITE 3 AC2 13 ASP B 289 SER B 290 GLY B 291 THR B 292 SITE 4 AC2 13 ALA B 396 CRYST1 86.353 89.978 131.636 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011580 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011114 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007597 0.00000 MASTER 337 0 2 24 60 0 8 6 0 0 0 64 END